Send me a link:

*Text messaging rates may apply.

 Dow Up 0.08% Nasdaq Up 0.23%

Orexigen Therapeutics, Inc. (OREX)

-NasdaqGS
5.35 Up 0.01(0.19%) 12:01PM EDT - Nasdaq Real Time Price
Prev Close:5.34
Open:5.38
Bid:5.35 x 600
Ask:5.36 x 5000
1y Target Est:11.63
Beta:1.78
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:5.30 - 5.43
52wk Range:4.60 - 7.84
Volume:969,627
Avg Vol (3m):3,430,220
Market Cap:622.35M
P/E (ttm):N/A
EPS (ttm):-0.82
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
OREXUp 0.19%622.35M
ABTDown 0.21%64.40B
GSKDown 0.06%120.37B
RHHBYUp 1.11%252.87B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):181.21
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.11
Quarterly EPS Est (Jun-14) :-0.09
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):0.14

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback